Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (15)
- (-) Climate Change (4)
- (-) Materials Science (28)
- (-) Neutron Science (24)
- (-) Security (3)
- 3-D Printing/Advanced Manufacturing (24)
- Advanced Reactors (7)
- Artificial Intelligence (7)
- Big Data (6)
- Bioenergy (12)
- Biology (3)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (5)
- Clean Water (2)
- Composites (1)
- Computer Science (31)
- Coronavirus (20)
- Critical Materials (2)
- Cybersecurity (3)
- Decarbonization (1)
- Energy Storage (14)
- Environment (16)
- Exascale Computing (3)
- Fusion (10)
- Grid (4)
- High-Performance Computing (3)
- Isotopes (7)
- Machine Learning (5)
- Materials (2)
- Mathematics (2)
- Mercury (1)
- Microscopy (6)
- Molten Salt (1)
- Nanotechnology (14)
- National Security (2)
- Nuclear Energy (24)
- Physics (13)
- Polymers (5)
- Quantum Science (12)
- Space Exploration (2)
- Summit (14)
- Sustainable Energy (15)
- Transformational Challenge Reactor (5)
- Transportation (10)
Media Contacts
Marcel Demarteau is director of the Physics Division at the Department of Energy’s Oak Ridge National Laboratory. For topics from nuclear structure to astrophysics, he shapes ORNL’s physics research agenda.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Paul J. Hanson, ORNL Corporate Fellow, has been elected to the 2020 Class of Fellows of the American Geophysical Union.
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
ORNL has added 10 virtual tours to its campus map, each with multiple views to show floor plans, rotating dollhouse views and 360-degree navigation. As a user travels through a map, pop-out informational windows deliver facts, videos, graphics and links to other related content.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.